Table 2.
Characteristics of lung abnormalities on chest computed tomography
| Clinical deterioration or death |
P value | ||
|---|---|---|---|
| Yes (N = 23) | No (N = 86) | ||
| Lung abnormality | |||
| Only ground-glass opacities | 0 (0.0) | 21 (24.4) | 0.008 |
| Only consolidation | 0 (0.0) | 1 (1.2) | 0.603 |
| Ground-glass opacities and consolidation | 22 (95.7) | 58 (67.4) | 0.007 |
| Pleural effusion | 7 (30.4) | 8 (9.3) | 0.009 |
| Emphysema | 3 (13.0) | 5 (5.8) | 0.238 |
| Fibrosis | 2 (8.7) | 3 (3.5) | 0.289 |
| None | 1 (4.3) | 6 (7.0) | 0.648 |
| Total pneumonia volume (mL) | 1040.1 (339.7–2100.7) | 282.6 (85.6–520.5) | <0.001 |
| Total pneumonia burden (%) | 19.6 (9.3–52.1) | 5.9 (1.7–11.6) | <0.001 |
| Lateralitya | |||
| Unilateral | 1 (4.5) | 10 (12.5) | 0.289 |
| Right | 1 (4.5) | 6 (7.5) | |
| Left | 0 (0.0) | 4 (5.0) | |
| Bilateral | 21 (95.5) | 70 (87.5) | |
| Lobar distributiona | |||
| Right upper lobe | 21 (26.3) | 65 (81.3) | 0.105 |
| Right medial lobe | 20 (25.0) | 64 (80.0) | 0.235 |
| Right lower lobe | 22 (27.5) | 73 (91.3) | 0.151 |
| Left upper lobe | 20 (25.0) | 68 (85.0) | 0.476 |
| Left lower lobe | 21 (26.3) | 72 (90.0) | 0.424 |
| Lobar involvementa | |||
| 1 lobe | 0 (0.0) | 5 (6.3) | 0.478 |
| 2 lobes | 1 (4.5) | 5 (6.3) | |
| 3 lobes | 1 (4.5) | 7 (8.8) | |
| 4 lobes | 1 (4.5) | 9 (11.3) | |
| 5 lobes | 19 (86.4) | 54 (67.5) | |
| Axial distributiona | |||
| Central | 0 (0.0) | 0 (0.0) | 0.046 |
| Peripheral | 6 (27.3) | 41 (51.3) | |
| Diffuse | 16 (72.7) | 39 (48.8) | |
a
calculated for patients with presence of COVID-19 pneumonia (n = 102).